Intestinal smooth muscle transit

Intestinal smooth muscle transit is a complex physiological process involving the coordinated movement of contents through the gastrointestinal tract via smooth muscle contractions known as peristalsis. This process is vital for effective digestion, nutrient uptake, and waste removal, and is regulated by a sophisticated interplay between the enteric nervous system, autonomic nervous system, and various endocrine signals (StatPearls, NBK526124). Although intestinal smooth muscle transit is frequently used as a primary endpoint in pharmacological studies—particularly in rodent charcoal meal assays—it represents a physiological phenotype or functional outcome rather than a single molecular target (PubMed, PMID: 28502866). Pharmacological intervention typically targets specific receptors, such as 5-HT4, mu-opioid, or motilin receptors, to either accelerate transit in cases of constipation or slow it down in cases of diarrhea. Clinical disorders associated with transit dysfunction include irritable bowel syndrome (IBS), gastroparesis, and chronic idiopathic constipation. Understanding the rate of transit is crucial for drug development, as it affects the pharmacokinetics of orally administered medications and serves as a marker for gastrointestinal safety (NIH, Gastrointestinal Motility and Transit).

Other names

Gastrointestinal transitGI transitIntestinal motilityGut motilityPeristalsis

Drugs modulate intestinal transit by interacting with specific molecular targets such as mu-opioid receptors (agonists slow transit), 5-HT4 receptors (agonists accelerate transit), or muscarinic receptors (antagonists slow transit).